During the past decade, TMC Life Research, Inc. conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 13 clinical trials were completed, i.e. on average, 65% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 10 clinical trials were completed. i.e. 142.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "TMC Life Research, Inc." #1 sponsor was "Scynexis, Inc." with 4 trials, followed by "Curatek Pharmaceuticals, LLC" with 3 trials sponsored, "Cidara Therapeutics Inc." with 2 trials sponsored, "Graceway Pharmaceuticals, LLC" with 2 trials sponsored and "Insud Pharma" with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "TMC Life Research, Inc." #1 collaborator was "Chemo Research" with 2 trials as a collaborator, "Chemo France" with 1 trials as a collaborator, "Daré Bioscience, Inc." with 1 trials as a collaborator, "Health Decisions" with 1 trials as a collaborator and "bioRASI, LLC" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "TMC Life Research, Inc." are "Contraception" (4 trials), "Vaginal Infection" (4 trials), "Candida Vulvovaginitis" (2 trials), "Candidiasis, Vulvovaginal" (2 trials) and "Change in Bone Mineral Density" (2 trials). Many other conditions were trialed in "TMC Life Research, Inc." in a lesser frequency.

Most popular intervention types in "TMC Life Research, Inc." are "Drug" (23 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Metronidazole" (3 trials), "Estradiol" (2 trials), "Fluconazole" (2 trials) and "Ibrexafungerp" (2 trials). Other intervention names were less common.

The vast majority of trials in "TMC Life Research, Inc." are 24 trials for "Female" genders and 2 trials for "All" genders.

Currently, there are NaN active trials in "TMC Life Research, Inc.". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in TMC Life Research, Inc., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in TMC Life Research, Inc., 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".